MedPath

Intradialytic Laughter Yoga therapy for haemodialysis patients: A pre-post intervention feasibility study

Not Applicable
Completed
Conditions
End stage kidney disease
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12614001130651
Lead Sponsor
A/Prof Paul Bennett
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
18
Inclusion Criteria

Haemodialysis patient
Monash Health
Consent

Exclusion Criteria

Unable to communicate in English

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective Wellbeing as measured by the Personal Wellbeing Index (PWI). This is a ten item valid and reliable measure. PArticipants are asked Thinking about your own life and personal circumstances, please circle the number that best represents how satisfied you feel with your life<br>1. Your life as a whole?<br>2. Your standard of living? <br>3. Your health? <br>4. What you are currently achieving in life? <br>5. Your personal relationships? <br>6. How safe you feel? <br>7. Feeling part of your community? <br>8. Your future security?<br>9. Your spirituality or religion? <br>Scale = 0 – 10.<br>Anchors: 0 – Not at all satisfied”; 10 – Completely satisfied”<br>[T1 is after 12 sessions of laughter yoga (4 weeks). Participants are asked to complete the T1 PWI following the final Laughter Yoga session. ]
Secondary Outcome Measures
NameTimeMethod
ung Funtion (FEV)[At exactly 28 days (4 weeks) following the final session PWI and Lung function measurements are taken. This is to measure any residual effects of the laughter yoga intervention.]
© Copyright 2025. All Rights Reserved by MedPath